Inari Medical Inc Revenue Growth Rates (NARI), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Inari Medical Inc   (NASDAQ: NARI)
 

NARI's Revenue Growth by Quarter and Year

Inari Medical Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NARI Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December -
3rd Quarter September 152.54
2nd Quarter June 144.83
1st Quarter March 142.30
FY 439.67





NARI Revenue third quarter 2024 Y/Y Growth Comment
Inari Medical Inc reported Revenue improvement of 21.17% year on year in the third quarter 2024, to $ 152.54 millions, this is lower than Inari Medical Inc 's recent average Revenue rise of 63.47%.
This represents worst decline in recent Company history.

Looking into third quarter 2024 results within Medical Equipment & Supplies industry 58 other companies have achieved higher Revenue growth. While Inari Medical Inc ' s Revenue rise of 21.17% ranks overall at the positon no. 781 in the third quarter 2024.


NARI Revenue ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter December - 22.95 % 29.5 % 71.2 %
3rd Quarter September 21.17 % 30.86 % 31.93 % 88.33 %
2nd Quarter June 21.7 % 28.33 % 46.16 % 149.9 %
1st Quarter March 22.49 % 33.91 % 51.13 % 112.99 %
FY   - 28.71 % 38.44 % -

Financial Statements
Inari Medical Inc 's third quarter 2024 Revenue $ 152.54 millions NARI's Income Statement
Inari Medical Inc 's third quarter 2023 Revenue $ 125.89 millions Quarterly NARI's Income Statement


NARI Revenue (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter December - 5.25 % 12.03 % 14.13 %
3rd Quarter September 5.33 % 5.78 % 3.73 % 14.93 %
2nd Quarter June 1.78 % 2.44 % 6.9 % 10.54 %
1st Quarter March 7.4 % 7.79 % 4.24 % 18.08 %
FY (Year on Year)   - 28.71 % 38.44 % -


Back to NARI Growth rate Comparisons >> Back to NARI Growth rate Comparisons >>


Revenue third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #59
Healthcare Sector #206
Overall #781

Revenue Y/Y Growth Statistics
High Average Low
172.16 % 63.47 % 21.17 %
(Jun 30 2021)   (Sep 30 2024)
Revenue third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #59
Healthcare Sector #206
Overall #781
Revenue Y/Y Growth Statistics
High Average Low
172.16 % 63.47 % 21.17 %
(Jun 30 2021)   (Sep 30 2024)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Inari Medical Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
88.63 % 14.7 % -5.79 %
(Dec 31 2019)  


NARI's III. Quarter Q/Q Revenue Comment
Inari Medical Inc achieved in the III. Quarter 2024 below company average Revenue increase of 5.33% quarter on quarter, to $ 152.54 millions.

Within Medical Equipment & Supplies industry 65 other companies have achieved higher Revenue quarter on quarter growth. While Inari Medical Inc 's Revenue growth quarter on quarter, overall rank is 1377.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #66
Healthcare Sector #251
Overall #1377
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #66
Healthcare Sector #251
Overall #1377
Revenue Q/Q Growth Statistics
High Average Low
88.63 % 14.7 % -5.79 %
(Dec 31 2019)  


NARI's III. Quarter Q/Q Revenue Comment
Inari Medical Inc achieved in the III. Quarter 2024 below company average Revenue increase of 5.33% quarter on quarter, to $ 152.54 millions.

Within Medical Equipment & Supplies industry 65 other companies have achieved higher Revenue quarter on quarter growth. While Inari Medical Inc 's Revenue growth quarter on quarter, overall rank is 1377.


Inari Medical Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)
Cumulative Revenue 12 Months Ending $ 572.18 $ 545.52 $ 519.70 $ 493.56 $ 468.83
Y / Y Revenue Growth (TTM) 22.04 % 24.22 % 25.87 % 28.71 % 30.62 %
Year on Year Revenue Growth Overall Ranking # 49 # 20 # 220 # 134 # 5
Seqeuential Revenue Change (TTM) 4.89 % 4.97 % 5.29 % 5.28 % 6.76 %
Seq. Revenue Growth (TTM) Overall Ranking # 1357 # 1090 # 981 # 786 # 336


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2024 period, Inari Medical Inc 's cumulative twelve months Revenue were $ 572 millions, company would post below average annual Revenue growth of 6.76% year on year, if the fiscal year would end at Sep 30 2024.
A slow-down in the Inari Medical Inc 's Revenue growth from the 144.83% growth in Jun 30 2024.

Among companies within the Healthcare sector 10 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 20 to 49.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 88
Healthcare Sector # 11
Overall # 49

Revenue TTM Y/Y Growth Statistics
High Average Low
433.72 %
 99.79 %
22.04 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 88
Sector # 272
S&P 500 # 1357
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2024 period, Inari Medical Inc 's cumulative twelve months Revenue were $ 572 millions, company would post below average annual Revenue growth of 22.04% year on year, if the fiscal year would end at Sep 30 2024.
A slow-down in the Inari Medical Inc 's Revenue growth from the 144.83% growth in Jun 30 2024.

Among companies within the Healthcare sector 10 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 20 to 49.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 88
Healthcare Sector # 11
Overall # 49

Revenue TTM Y/Y Growth Statistics
High Average Low
433.72 %
99.79 %
22.04 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 88
Sector # 272
S&P 500 # 1357




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NARI's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Sep 30 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2024
Hyperfine Inc 36.91%$ 36.911 millions
Mannkind Corporation36.73%$ 36.732 millions
Lyell Immunopharma Inc 36.00%$ 36.000 millions
Hyperion Defi inc 35.64%$ 35.643 millions
Sanara Medtech Inc 35.39%$ 35.394 millions
Elite Pharmaceuticals Inc 35.33%$ 35.326 millions
Orthopediatrics Corp35.31%$ 35.309 millions
Biocryst Pharmaceuticals Inc 34.98%$ 34.981 millions
T2 Biosystems Inc 34.85%$ 34.851 millions
Biodesix Inc 34.54%$ 34.542 millions
Dih Holding Us Inc 34.43%$ 34.433 millions
Halozyme Therapeutics Inc 34.28%$ 34.278 millions
Guardant Health Inc 33.87%$ 33.871 millions
Cvrx inc 33.66%$ 33.656 millions
Inspire Medical Systems inc 32.61%$ 32.614 millions
Butterfly Network Inc 31.54%$ 31.537 millions
Tandem Diabetes Care Inc 31.26%$ 31.263 millions
Tela Bio Inc 31.06%$ 31.058 millions
Sonoma Pharmaceuticals Inc 31.05%$ 31.051 millions
Star Equity Holdings Inc 30.93%$ 30.934 millions
Pacs Group Inc 30.05%$ 30.046 millions
Ethema Health Corporation 29.99%$ 29.995 millions
The Pennant Group Inc 28.89%$ 28.886 millions
Interpace Biosciences Inc 28.50%$ 28.501 millions
Biomarin Pharmaceutical Inc28.28%$ 28.282 millions
Beone Medicines Ltd 28.14%$ 28.136 millions
Zevra Therapeutics Inc 27.63%$ 27.634 millions
Scorpius Holdings inc 27.55%$ 27.552 millions
Adc Therapeutics Sa27.40%$ 27.399 millions
Cervomed Inc 27.07%$ 27.073 millions


About Inari Medical Inc Revenue Growth Rates (NARI), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Inari Medical Inc (CIK 1531048).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001531048-24-000060
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Inari Medical Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.